Vadim Koshkin

Vadim Koshkin: Genomic Biomarkers Associated with EV Outcomes for Patients with Advanced Urothelial Carcinoma

Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, shared a recent article by him and colleagues on X:

“Our latest Unite publication in European Urology Oncology led by Tanya Jindal.

Biomarkers of EV outcomes: TMB associated with improved OS while CDKN2A/CDKN2B alteration with inferior PFS.”

“Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data”

Authors: Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen, Rafee Talukder, Dimitra Bakaloudi, Matthew Davidsohn, Dory Freeman, Michael Glover, Ali Raza Khaki, Sean Evans, Emily Lemke, Rohit Bose, Woogwang Sim, Cameron Pywell, Arnab Basu, Deepak Kilari, Pedro C. Barata, Mehmet A. Bilen, Yousef Zakharia, Matthew I. Milowsky, Sumit A. Shah, Joaquim Bellmunt, Petros Grivas, Hamid Emamekhoo, Nancy B. Davis, Shilpa Gupta, Christopher Holmes, Matthew T. Campbell, Ajjai Alva, Vadim S. Koshkin.

Vadim Koshkin

More posts featuring Vadim Koshkin.

Ajjai Alva Ali Raza Khaki. Amanda Nizam Arnab Basu Cameron Pywell cancer Charles Nguyen Christopher Holmes Cindy Jiang Deepak Kilari Dimitra Bakaloudi Dory Freeman Emily Lemke European Urology Oncology Hamid Emamekhoo Joaquim Bellmunt Matthew Davidsohn Matthew I. Milowsky Matthew T Campbell Mehmet A Bilen Michael Glover Nancy B. Davis Omar Alhalabi OncoDaily Oncology Pedro C Barata Petros Grivas Rafee Talukder Rohit Bose Sean Evans Shilpa Gupta Sumit A. Shah Tanya Jindal urothelial carcinoma Vadim Koshkin Woogwang Sim Yousef Zakharia